TABLE 1.
Specificity of rbhIL-2-SA-FITC conjugate bindinga
| Stimulant | Ab specificity | % of cells positive forb:
|
|
|---|---|---|---|
| rbhIL-2-SA-FITC | SA-FITC | ||
| PHA | CD3 (T) | 20.97 ± 1.75 | 0.06 ± 0.02 |
| CD19 (B) | 2.39 ± 0.14 | 0.05 ± 0.00 | |
| TT | CD3 (T) | 4.09 ± 0.17 | 0.00 ± 0.00 |
| CD19 (B) | 0.48 ± 0.20 | 0.00 ± 0.00 | |
a
The analysis represents the examination of the lymphocyte population only, as determined by forward and side scatter.
b
Data represent the percentage of cells positive for binding of rbhIL-2-SA-FITC or SA-FITC and Ab against the indicated markers.